NATACYN (NATAMYCIN OPHTHALMIC SUSPENSION) 5%

LIVE

Serial Number

98402032

Owner

Harrow IP, LLC

Attorney

Laila S. Wolfgram

First Use Date

Jun 25, 2025

Filing Date

Feb 12, 2024

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

NATACYN (NATAMYCIN OPHTHALMIC SUSPENSION) 5% Trademark

Serial Number: 98402032 • Registration: 8275052

NATACYN (NATAMYCIN OPHTHALMIC SUSPENSION) 5% is a trademark filed by Harrow IP, LLC on February 12, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Harrow IP, LLC (7 trademarks)

102 Woodmont Blvd, Suite 610
Nashville, TN 37205

Entity Type: 16

Legal Representation

Attorney of Record

Laila S. Wolfgram

1,184 trademarks filed View all →

Correspondence Address

Laila S. Wolfgram POLSINELLI PC

PO BOX 140310

KANSAS CITY, MO 64114-0310

United States

Trademark Details

Filing Date

February 12, 2024

Registration Date

May 26, 2026

First Use Anywhere

June 25, 2025

First Use in Commerce

June 25, 2025

Published for Opposition

February 25, 2025

Goods & Services

Pharmaceutical compositions for ophthalmological use containing natamycin; topical antifungal compositions for ophthalmological use containing natamycin

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 26, 2026 NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 26, 2026 NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 26, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

May 26, 2026 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 5, 2026 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 5, 2026 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Apr 7, 2026 SUPC

USE AMENDMENT FILED

Oct 22, 2025 IUAF

TEAS STATEMENT OF USE RECEIVED

Oct 22, 2025 EISU

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 8, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Oct 8, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Oct 8, 2025 REAP

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 22, 2025 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 25, 2025 NPUB

PUBLISHED FOR OPPOSITION

Feb 25, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 19, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 3, 2025 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 8, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 7, 2025 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 7, 2025 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 7, 2024 GNRN

NON-FINAL ACTION E-MAILED

Oct 7, 2024 GNRT

NON-FINAL ACTION WRITTEN

Oct 7, 2024 CNRT

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Oct 2, 2024 ZZZX

WITHDRAWN FROM PUB - OG REVIEW QUERY

Oct 1, 2024 PBCR

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 17, 2024 CNSA

EXAMINER'S AMENDMENT ENTERED

Sep 12, 2024 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 12, 2024 GNEN

EXAMINERS AMENDMENT E-MAILED

Sep 12, 2024 GNEA

EXAMINERS AMENDMENT -WRITTEN

Sep 12, 2024 CNEA

ASSIGNED TO EXAMINER

Sep 5, 2024 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 18, 2024 NWOS

NEW APPLICATION ENTERED

Feb 12, 2024 NWAP

Related Trademarks

More from this Owner

HARROW CARES

More in Same Class

ODDITY

IHEEZO (CHLOROPROCAINE HCI OPHTHALMIC GEL) 3%